Work

Effects of Anti-inflammatory on Neurodegenerative disorder

Year: 2026
Type: article
Abstract: Elderly populations are expected to increase, leading to an increase in neurodegenerative diseases such as Alzheimer's Disease (AD), Parkinson's Disease (PD), Amyotrophic Lateral Sclerosis (ALS), and Huntington's Disease (HD). The role of neuroinflammation in the onset and progression of these diseases is becoming increasingly apparent. There are numerous studies demonstrating that, following chronic activation of microglia and astrocytes, pro-inflammatory cytokine release occurs at excessive levels, oxidative stress and mitochondrial dysfunction are present, and pathological proteins aggregate and lead to progressive neuronal death. The NLRP3 inflammasome plays an important role as a link between innate immune activation and synaptic dysfunction and neuronal apoptosis. This article examines the therapeutic potential of various strategies to manage neurodegenerative diseases through reducing inflammation in the central nervous system. These strategies may include using non-steroidal anti-inflammatory drugs (NSAIDs), COX-2-selective inhibitors, tetracycline derivatives, therapies aimed at inhibiting the NLRP3 inflammasome, and antioxidant-based therapies. Preclinical research shows that these agents have the ability to reduce microglial activation, cytokine release, oxidative damage to neurons, and promote neuron survival. However, clinical results have been inconsistent due to the complexity of these diseases, the variability of individual inflammatory responses, variability in blood-brain barrier permeability, issues of safety, and the time of intervention. New research is focusing on identifying neuroinflammatory biomarkers as well as exploring the use of selective immunomodulator therapy, combination therapy, and precision medicine with the ultimate goal of developing effective disease-modifying therapies through a better understanding of the interactions between neuroimmune systems.
Language: English
Subfield: Neurology
Open Access status: green
OpenAlex ID: W7203870550
FWCI:
Cites:
Cited by:
Related to: 10